Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Christian Angermayer · Said 14 Jun 2024 · angermayer-0185
Quote
Not a forecast
“it isn't MDMA itself that was rejected per se, but the specific poor data set provided by Lykos Therapeutics.”
The Microdose round-up of industry reactions to the advisory committee vote quotes him saying the Lykos data package, not MDMA, is the problem.
Descriptive, retrospective, or a statement of preference; no future state asserted.